Hirudins, ornatins and piscicolins in representatives of freshwater and marine piscicolid leeches
This study reveals that freshwater and marine piscicolid leeches possess distinct repertoires of hirudin-like anticoagulants, including species-specific ornatins and hirudin-like factors alongside a newly identified, evolutionarily conserved group of "piscicolins," suggesting that the ancestral hirudin superfamily gene was already present at the origin of true leeches.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Deep within the watery realms of rivers, lakes, and oceans, a specialized group of parasites waits for its next meal. These are the fish leeches, blood-sucking creatures that attach themselves to fish and other aquatic animals to feed. While they are often seen as pests that can harm fish populations and damage aquaculture operations, they are also biological factories. For centuries, scientists have known that leeches produce powerful chemicals in their saliva to stop their hosts' blood from clotting. This allows the leech to drink freely without the wound sealing shut. The most famous of these chemicals, known as hirudin, was discovered in the medicinal leech and has become a vital tool in modern medicine for treating blood clots. Another important group of chemicals, called ornatins, stops blood cells called platelets from sticking together, which is the first step in forming a clot. For a long time, researchers wondered if these same powerful tools existed in the fish-eating leeches, which belong to a different family and live in very different environments.
A team of researchers set out to solve this mystery by looking directly at the genetic blueprints of two very different fish leeches. They examined the complete genome, or the full set of instructions, of the European fish leech, which lives in fresh water, and a marine fish leech found in the Pacific Ocean. By reading these genetic codes, they were searching for the specific genes that would tell the leeches how to make hirudin and ornatin. The results were a mix of surprise and discovery. In the European fish leech, they found the genes for both hirudin-like factors and ornatins, confirming that this species possesses the same chemical toolkit as its freshwater cousins. However, in the marine fish leech, these specific genes were completely missing. This was a significant finding because it suggested that the ability to make these specific blood-thinning agents might not be universal among all fish leeches.
But the story did not end with a simple yes or no. While the marine leech lacked the expected genes, the researchers discovered something entirely new hiding in its DNA. They found a different type of gene that they named "piscicolin." These genes produce proteins that share some structural features with the known blood-thinning agents but are built differently. The most striking difference lies in how the genetic instructions are arranged. In the genes for hirudin and ornatin, the instructions are split into two parts. In the new piscicolin genes, the instructions are split into three parts, creating a slightly different distance between key building blocks within the protein. This structural difference suggests that piscicolins are a distinct family of blood-thinning agents that evolved separately.
The researchers did not stop at just finding the genes; they wanted to know if these new chemicals actually worked. They took the genetic instructions for a piscicolin from a marine leech species and used bacteria to manufacture the protein in a lab. When they tested this new protein on human blood platelets, they found that it did indeed stop the platelets from clumping together, though the effect was weaker than that of the most potent known agents. This confirmed that the gene was functional and produced a real biological effect. The team also looked at genetic data from several other marine leech species and found that these new piscicolin genes were widespread among them, appearing in both fresh and salt-water environments.
The findings paint a clearer picture of how these parasites have evolved. The research suggests that the common ancestor of all true leeches already possessed the genetic potential to make hirudin and ornatin. Over millions of years, some lineages, like the marine fish leech, lost the ability to make the classic versions of these chemicals but instead developed the new piscicolin family. This discovery fills a major gap in our understanding of leech evolution, showing that the genetic toolkit for stopping blood clotting is more diverse and adaptable than previously thought. By mapping out these genes, scientists have not only identified new potential tools for medicine but also traced a unique evolutionary path that these ancient parasites have taken to survive in the world's waters.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.